Comment on: the influence of the pharmaceutical industry on the off-label use of its medicines
Gebhardt draws attention to an important issue. The responsibility for informing and warning patients about adverse effects and how to prevent them, or …
| Auteur principal: | |
|---|---|
| Type de support: | Électronique Article |
| Langue: | Anglais |
| Vérifier la disponibilité: | HBZ Gateway |
| Interlibrary Loan: | Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany) |
| Publié: |
2002
|
| Dans: |
Journal of medical ethics
Année: 2002, Volume: 28, Numéro: 4, Pages: 277 |
| Accès en ligne: |
Volltext (JSTOR) Volltext (kostenfrei) Volltext (kostenfrei) |
| Résumé: | Gebhardt draws attention to an important issue. The responsibility for informing and warning patients about adverse effects and how to prevent them, or … |
|---|---|
| ISSN: | 1473-4257 |
| Contient: | Enthalten in: Journal of medical ethics
|
| Persistent identifiers: | DOI: 10.1136/jme.28.4.277-a |
